Effects of neuroglobin overexpression on acute brain injury and long-term outcomes after focal cerebral ischemia

Stroke. 2008 Jun;39(6):1869-74. doi: 10.1161/STROKEAHA.107.506022. Epub 2008 Apr 10.

Abstract

Background and purpose: Emerging data suggest that neuroglobin (Ngb) may protect against hypoxic/ischemic neuronal insults. However, the underlying mechanisms in vivo and implications for long-term outcomes are still not well understood.

Methods: Using our newly created Ngb overexpressing transgenic (Ngb-Tg) mice, we measured brain infarction on day 1 and day 14 after transient focal cerebral ischemia and performed neurobehavioral assessments in sensorimotor deficits on days 1, 3, 7, and 14. To test the hypothesis that Ngb may play a role in reducing oxidative stress after stroke, intracellular malondialdehyde levels were measured and compared in Ngb-Tg and wild-type mice.

Results: Increased Ngb mRNA and protein levels were identified in Ngb-Tg brains. Malondialdehyde levels in ischemic hemispheres of Ngb-Tg were significantly reduced compared with wild-type controls at 8 hours and 22 hours after transient focal cerebral ischemia. Compared with wild-type controls, brain infarction volumes 1 day and 14 days after transient focal cerebral ischemia were significantly reduced in Ngb-Tg mice. However, there were no significant improvements in sensorimotor deficits for up to 14 days after stroke in Ngb-Tg mice compared with wild-type controls.

Conclusions: Ngb reduces tissue infarction and markers of oxidative stress after stroke. Tissue protection by overexpressing Ngb can be sustained for up to 2 weeks.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease / therapy
  • Animals
  • Biomarkers / metabolism
  • Brain Ischemia / genetics
  • Brain Ischemia / metabolism*
  • Brain Ischemia / physiopathology
  • Cerebral Infarction / genetics
  • Cerebral Infarction / metabolism*
  • Cerebral Infarction / physiopathology
  • Cytoprotection / genetics
  • Disease Models, Animal
  • Gene Expression Regulation / genetics
  • Genetic Therapy / methods
  • Globins / genetics
  • Globins / metabolism*
  • Malondialdehyde / metabolism
  • Mice
  • Mice, Transgenic
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism*
  • Neuroglobin
  • Oxidative Stress / genetics*
  • RNA, Messenger / metabolism
  • Time
  • Time Factors
  • Up-Regulation / genetics

Substances

  • Biomarkers
  • Nerve Tissue Proteins
  • Neuroglobin
  • RNA, Messenger
  • Malondialdehyde
  • Globins